FDA Holds Back MDMA Psychedelic Therapy Over Safety, Efficacy Concerns

A company seeking to treat post-traumatic stress disorder with a combination of MDMA and talk therapy just suffered a major setback from the U.S. Food and Drug Administration. Lykos Therapeutics, th… [+1778 chars]

FDA Holds Back MDMA Psychedelic Therapy Over Safety, Efficacy Concerns

FDA Holds Back MDMA Psychedelic Therapy Over Safety, Efficacy Concerns

FDA Holds Back MDMA Psychedelic Therapy Over Safety, Efficacy Concerns

FDA Holds Back MDMA Psychedelic Therapy Over Safety, Efficacy Concerns

FDA Holds Back MDMA Psychedelic Therapy Over Safety, Efficacy Concerns